Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Food Effect of AL-794 in Healthy Subjects
NCT02877160Phase 1Completed
- Sponsor
- Alios BioPharma
- Start
- Jun 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of AL-794 in influenza (3 arms), sponsored by Alios BioPharma. Primary endpoint: Area under the concentration-time curve from time of dosing to infinity of ALS-033719. Started Jun 2016; status: completed.
02
Drugs
AL-794
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02877160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02877160.